banner

Blog back to homepage

Andes Gold Corp. Stock Chart Analysis Video Andes Gold Corp. Stock Chart Analysis Video(0)

The stock chart for Andes Gold Corporation (Pink Sheets: AGCZ) is in a solid uptrend in 2012; moving from a penny to touch $0.068 in the past two months.  Both the 50 and 200 day simple moving averages are trending upward with the pps holding well above those key markers.  Support is established at $0.05 and again at $0.0425.  There is little resistance in sight until the pps moves to challenge the recent 52-week high at $0.068. Read More

Stocks Slip at Open on Fourth Quarter GDP Stocks Slip at Open on Fourth Quarter GDP(0)

The U.S. economy expanded in the fourth quarter of 2011 basically right in line with economists’ predictions.  In the Commerce Department’s final estimate released this morning, gross domestic product (GDP) increased at a 3.0 percent annual rate in the final quarter after a 1.8 percent growth rate during the third quarter.  This is the fastest clip since the second quarter of 2010.  Read More

Salamon Group Lands New Solar Projects Salamon Group Lands New Solar Projects(0)

Solar energy company Salamon Group, Inc. (OTCQB: SLMU) reported that it secured the rights to build solar power systems on the rooftops of 23 schools in Williamson County Tennessee.   The Las Vegas-based company will immediately start building 3 solar power systems with an output of 200 kilowatts each, which will equate to $3.3 million Read More

Optimer and Astellas Partner on Clostridium Difficile Infection Drug Optimer and Astellas Partner on Clostridium Difficile Infection Drug(0)

San Diego, California-based Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Tokyo-based Astelllas Pharma Inc. (Pink Sheets: ALPMY, Tokyo: 4503) reported this morning that the execution of an exclusive collaboration and license agreement to develop and commercialize fidaxomicin tablets in Japan for the treatment of Clostridium difficile Infection (CDI). Read More

ChromaDex Launches Aggressive Marketing Campaign for BluScience ChromaDex Launches Aggressive Marketing Campaign for BluScience(0)

A new multi-million national media campaign has been launched by Irvine, California’s ChromaDex Corporation (OTCBB:CDXC) for its recently commercialized BluScience™ line of dietary supplements.  The help facilitate the media blitz – which will include television, radio and digital outlets – ChromaDex has retained RJ Palmer, a NYC-based full service media agency with billings in excess of $800 million.  RJ Palmer, a subsidiary of Read More

Why Enviro Voraxial Technologies Can Fill A Void For Companies Like Exxon And BP Why Enviro Voraxial Technologies Can Fill A Void For Companies Like Exxon And BP(0)

John DiBella, president and CEO of Enviro Voraxial Technologies, Inc. (OTCBB:EVTN), released a statement in January of this year. Dibella confirmed that EVTN had met its revenue increase of 250% for fiscal year 2011. He also feels confident Read More

Empire Post Media Making 3D E-Book Based on “A Fairway to Heaven” Empire Post Media Making 3D E-Book Based on “A Fairway to Heaven”(0)

Golf’s a hot topic again with Tiger finally getting off the schneid with his five-stroke victory at Bay Hill ending a 30-month drought. Yes, Tiger certainly has a way of invigorating the sport. But any die-hard golfer (or even just a fan) loves a lot more about the game than the just the “Hollywood flavor” that TW brings to it. Read More

MMRGlobal CEO Bob Lorsch Featured on BravoTV’s “Interior Therapy” MMRGlobal CEO Bob Lorsch Featured on BravoTV’s “Interior Therapy”(0)

Last Wednesday, March 21, 2012, the BravoTV show “Interior Therapy with Jeff Lewis” featured a renovation of the home of MMRGlobal, Inc. (OTCBB:MMRF) Chief Executive Officer Robert Lorsch.  At OTC Showcase, we have followed and written on MMRGlobal and its chief for a number of years pertaining to corporate developments as well as the backdrop of stories surrounding Lorsch, including his philanthropic efforts with Read More

Sunshine Biopharma Shares Jump on Multi-Drug Resistant Breast Cancer Presentation News Sunshine Biopharma Shares Jump on Multi-Drug Resistant Breast Cancer Presentation News(0)

With the backdrop of news on Monday that Sunshine Biopharma, Inc. (OTCBB:SBFM) will be presenting new scientific data at the American Association for Cancer Research Meeting in Chicago, IL (to be held on March 31 – April 4, 2012), shares of the junior biotech surged a cool 100% to close Monday’s trading at 50 cents each. Read More

Deploy Technologies Weighs In With First Sales Order Deploy Technologies Weighs In With First Sales Order(0)

Vancouver-based Deploy Technologies, Inc. (Pink Sheets:DPLY) reported this morning that it has received its first sales order from Sea To Sky Transfer, a British Columbia-based transportation company specializing in Read More



Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.